These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15599014)

  • 21. Hepatitis-B vaccination.
    Phadke A; Kale A
    J Indian Med Assoc; 2004 May; 102(5):270. PubMed ID: 15636033
    [No Abstract]   [Full Text] [Related]  

  • 22. JCVI response on hepatitis B vaccination.
    Joint Committee on Vaccination and Immunisation
    Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
    [No Abstract]   [Full Text] [Related]  

  • 23. Choosing Wisely: five ideas that physicians and patients can discuss.
    Parke DW; Coleman AL; Rich WL; Lum F
    Ophthalmology; 2013 Mar; 120(3):443-444. PubMed ID: 23714602
    [No Abstract]   [Full Text] [Related]  

  • 24. Changing Physician Behavior Is Harder Than We Thought.
    Wilensky G
    JAMA; 2016 Jul; 316(1):21-2. PubMed ID: 27380330
    [No Abstract]   [Full Text] [Related]  

  • 25. Low-key, low-cost 'education' for physicians sparks savings.
    Montague J
    Hosp Health Netw; 1993 Jun; 67(11):70. PubMed ID: 8499972
    [No Abstract]   [Full Text] [Related]  

  • 26. Can physicians practice cost-effective medicine?
    Conti CR
    Clin Cardiol; 1998 Jan; 21(1):2-3. PubMed ID: 9474458
    [No Abstract]   [Full Text] [Related]  

  • 27. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.
    Aggarwal R; Ghoshal UC; Naik SR
    J Hepatol; 2003 Feb; 38(2):215-22. PubMed ID: 12547411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Confusing games of public insurance with hepatitis B vaccinations. Interview by Dr. rer. nat. Anita Schweiger].
    Eichhorn R
    Fortschr Med; 1997 Apr; 115(10):41. PubMed ID: 9206686
    [No Abstract]   [Full Text] [Related]  

  • 30. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
    Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
    Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of hepatitis B serology testing before hepatitis B vaccination in the Akha tribal children in northeastern Thailand.
    Custodio H; Mirza A; Salahuddin A; Ferguson K; Rathore M
    Pediatr Infect Dis J; 2011 Aug; 30(8):725. PubMed ID: 21750450
    [No Abstract]   [Full Text] [Related]  

  • 32. Editor's Spotlight/Take 5: Universal Health Insurance Coverage in Massachusetts Did Not Change the Trajectory of Arthroplasty Use or Costs.
    Manner PA
    Clin Orthop Relat Res; 2016 May; 474(5):1086-9. PubMed ID: 26968725
    [No Abstract]   [Full Text] [Related]  

  • 33. The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries.
    Chauvin P; Ekra D; Plotkin SA
    Vaccine; 2002 Jul; 20(23-24):2848-50. PubMed ID: 12126893
    [No Abstract]   [Full Text] [Related]  

  • 34. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
    Sun PP; Zhang SX; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of hepatitis B infection: the appropriate strategy for India.
    Aggarwal R; Naik SR
    Natl Med J India; 1994; 7(5):216-20. PubMed ID: 7827601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of running a universal adolescent hepatitis B vaccination programme.
    Wallace LA; Young D; Brown A; Cameron JC; Ahmed S; Duff R; Carman WF; Kitchin NR; Nguyen-Van-Tam JS; Goldberg DJ
    Vaccine; 2005 Dec; 23(48-49):5624-31. PubMed ID: 16099079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Economic evaluation of various hepatitis B vaccination strategies in children and adolescents].
    Szucs TD; Smala A; Berger K; Windorfer A
    Med Klin (Munich); 1998 Aug; 93(8):468-77. PubMed ID: 9747102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus.
    Arevalo JA; Washington AE
    JAMA; 1988 Jan; 259(3):365-9. PubMed ID: 2961895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Routine hepatitis B immunization in India: cost effectiveness needs reassessment.
    Puliyel JM; Mittal R; Tyagi V; Gupta S
    Indian J Pediatr; 2003 Feb; 70(2):188. PubMed ID: 12661821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.